A review on global threat corona virus disease: COVID-19

Samia  begam Barbhuiya; Vicky Bareh; Caroline Malsawmtluangi; Parikshit Das

doi:10.18231/j.joapr.2020.v.8.i.4.10.15

Authors

Samia begam Barbhuiya Regional Institute of Paramedical and Nursing Sciences, Zemabawk, Aizawl, Mizoram, 796017
Vicky Bareh Regional Institute of Paramedical and Nursing Sciences, Zemabawk, Aizawl, Mizoram, 796017
Caroline Malsawmtluangi Regional Institute of Paramedical and Nursing Sciences, Zemabawk, Aizawl, Mizoram, 796017
Parikshit Das Regional Institute of Paramedical and Nursing Sciences, Zemabawk, Aizawl, Mizoram, 796017

DOI:

https://doi.org/10.18231/j.joapr.2020.v.8.i.4.10.15

Keywords:

SARS-CoV 2, RNA, Broad spectrum, Antibiotic, Interferon alpha

Abstract

Corona virus disease is a kind of viral disease caused by Severe Acute Respiratory Syndrome- CoV 2, which is first witnessed in Wuhan city, China and it can be transmit from human to human. Coronavirus size ranges from (65-125 nm) in diameter and contain a single stranded RNA as nucleic acid material, size ranging from 26 to 32 kbps in length. The sub group of coronaviruses family is Alpha (α) Beta (β) Gama (γ) and delta (δ) coronavirus. Coronavirus disease is a kind of respiratory disease which mainly affects the lower respiratory tract of human body. Initially interferon α normalisation, broad spectrum antibiotic and antiviral drugs was used to reduce the viral load. There may be different kind of mode of transmission of this virus for example Respiratory transmission, Aerosol transmission, Contact transmission and Hospital acquired transmission. There is a well explained safety measures is provided to inhibit the COVID-19 spread which should be followed properly. There are some testing processes also developed to determine the presence of this virus. Till now not even a single vaccine is developed for the treatment of this COVID-19 but more than 12 countries across the globe are undergoing trial for more than 150 vaccine candidates.

Downloads

Download data is not yet available.

References

Moujaess E, Kourie HR, Ghosn M. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence. Crit. Rev. Oncol. Hematol., 150, 102972 (2020).

Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin Y fan, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J. Infect., 80, 656–65 (2020).

Reis RF, de Melo Quintela B, de Oliveira Campos J, Gomes JM, Rocha BM, Lobosco M, dos Santos RW. Characterization of the COVID-19 pandemic and the impact of uncertainties, mitigation strategies, and underreporting of cases in South Korea, Italy, and Brazil. Chaos, Solitons & Fractals, 136, 109888 (2020).

Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Sci. Total Environ., 730, 138996 (2020).

Disease CV. / Saｒs3 Covid- 19 1, 2020.

Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev., (2020).

Robson B. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance. Comput. Biol. Med., 121, 103749 (2020).

Liu Z, Magal P, Seydi O, Webb G. A COVID-19 epidemic model with latency period. Infect. Dis. Model., 5, 323–37 (2020).

Díaz LA, García-Salum T, Fuentes-López E, Ferrés M, Medina RA, Riquelme A, Levican J, Almonacid LI, Serrano E, Chahuan J, Cofré C, Álvarez M, Labarca J, Valderrama S, Salinas E, Toro A, Ortega M, García P, Pizarro M. Symptom profiles and risk factors for hospitalization in patients with SARS-CoV-2 and COVID-19: A Large Cohort from South America. Gastroenterology, (2020).

Cevik M, Bamford C, Ho A. COVID-19 pandemic - A focused review for clinicians. Clin. Microbiol. Infect.,26, 842 – 847 (2020).

Fang-Guo L, Tao W, Wen-Ming X, Ping W, zhao Cheng. Discussion on Etiology and Pathogenesis of Corona Virus Disease 2019 from “Cold-dampness and Insidious Dryness”. Digit. Chinese Med., 3, 50–4 (2020).

Abed M, Abdeen S, Kehyayan V. The first few cases and fatalities of Corona Virus Disease 2019 ( COVID-19 ) in the Eastern Mediterranean Region of the World Health Organization : A rapid review. J. Infect. Public Health, 2019, (2020).

Sharma E. Corona virus (Covid-19) – ITS implications in pediatric orthopedic care. J. Orthop., (2020).

Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain. Behav. Immun., 87, 34–9 (2020).

Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am. J. Emerg. Med., 11–3 (2020).

Halim AA, Alsayed B, Embarak S, Yaseen T, Dabbous S. Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients. Egypt. J. Chest Dis. Tuberc., 65, 81–7 (2016).

Wang D, Zhou M, Nie X, Qiu W, Yang M, Wang X, Xu T, Ye Z, Feng X, Xiao Y, Chen W. Epidemiological characteristics and transmission model of Corona Virus Disease 2019 in China. J. Infect., 80, e25–7 (2020).

Chen HW, Huang CY, Lin SY, Fang ZS, Hsu CH, Lin JC, Chen YI, Yao BY, Hu CMJ. Synthetic virus-like particles prepared via protein corona formation enable effective vaccination in an avian model of coronavirus infection. Biomaterials, 106, 111–8 (2016).

Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol., 79, 104212 (2020).

Besser A, Lotem S, Zeigler-Hill V. Psychological Stress and Vocal Symptoms among University Professors in Israel: Implications of the Shift to Online Synchronous Teaching during the COVID-19 Pandemic. J. Voice, (2020).

Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am. J. Otolaryngol., 41, 102581 (2020).

Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int. J. Antimicrob. Agents, 106024 (2020).

Prattes J, Valentin T, Hoenigl M, Talakic E, Reisinger AC, Eller P. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. Med. Mycol. Case Rep., 1–4 (2020).

Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, Summer R, DeSimone J, Sundaram B. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic. Am. J. Med. Sci., (2020).

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public